Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Fradet

Showing results (31-40 of 240) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|February 10, 2007
MAGE-A9 mRNA and protein expression in bladder cancerValérie Picard, Alain Bergeron, Hélène Larue, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
The burden of prostate cancer in CanadaYves Fradet, Laurence Klotz, John Trachtenberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinomaBernard Têtu, Rabi Tiguert, François Harel, et al.
The Journal of Urology|July 11, 2003
Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen levelRabi Tiguert, Jérôme Rigaud, Louis Lacombe, et al.
The Canadian Journal of Urology|November 2, 2006
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancerFrançois Meyer, Bernard Têtu, Isabelle Bairati, et al.
Human Pathology|March 11, 2008
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistryDominique Trudel, Yves Fradet, François Meyer, et al.
The Journal of Urology|March 23, 2011
Toll-like receptors in normal and malignant human bladdersCherifa Ayari, Alain Bergeron, Hélène LaRue, et al.
Cancer|May 13, 2009
Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortalityBrant A Inman, Viet-Tan Tran, Yves Fradet, et al.
The Journal of Urology|July 20, 2002
Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis?Mireille Grégoire, Frédéric Liandier, Alain Naud, et al.
Cancer Research|December 18, 2003
Significance of MMP-2 expression in prostate cancer: an immunohistochemical studyDominique Trudel, Yves Fradet, François Meyer, et al.
Pageof 24

Showing results (31-40 of 240) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|February 10, 2007
MAGE-A9 mRNA and protein expression in bladder cancerValérie Picard, Alain Bergeron, Hélène Larue, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2009
The burden of prostate cancer in CanadaYves Fradet, Laurence Klotz, John Trachtenberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinomaBernard Têtu, Rabi Tiguert, François Harel, et al.
The Journal of Urology|July 11, 2003
Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen levelRabi Tiguert, Jérôme Rigaud, Louis Lacombe, et al.
The Canadian Journal of Urology|November 2, 2006
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancerFrançois Meyer, Bernard Têtu, Isabelle Bairati, et al.
Human Pathology|March 11, 2008
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistryDominique Trudel, Yves Fradet, François Meyer, et al.
The Journal of Urology|March 23, 2011
Toll-like receptors in normal and malignant human bladdersCherifa Ayari, Alain Bergeron, Hélène LaRue, et al.
Cancer|May 13, 2009
Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortalityBrant A Inman, Viet-Tan Tran, Yves Fradet, et al.
The Journal of Urology|July 20, 2002
Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis?Mireille Grégoire, Frédéric Liandier, Alain Naud, et al.
Cancer Research|December 18, 2003
Significance of MMP-2 expression in prostate cancer: an immunohistochemical studyDominique Trudel, Yves Fradet, François Meyer, et al.
Pageof 24